Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-08-31 4:52 pm Purchase |
2021-08-23 | 13D | Acutus Medical, Inc. AFIB |
ORBIMED ADVISORS LLC | 6,881,953 7.700% |
1,071,428 (+18.44%) |
Filing History |
| 2021-08-16 4:45 pm Unchanged |
2021-08-12 | 13D | Ikena Oncology, Inc. IKNA |
ORBIMED ADVISORS LLC | 1,936,886 5.400% |
0 (Unchanged) |
Filing History |
| 2021-08-12 4:17 pm Sale |
2021-08-10 | 13D | ORIC Pharmaceuticals, Inc. ORIC |
ORBIMED ADVISORS LLC | 2,212,571 5.600% |
-254,721 (-10.32%) |
Filing History |
| 2021-08-04 5:21 pm Unchanged |
2021-08-02 | 13D | Corvus Pharmaceuticals, Inc. CRVS |
ORBIMED ADVISORS LLC | 8,053,298 19.000% |
0 (Unchanged) |
Filing History |
| 2021-07-14 5:08 pm Purchase |
2021-07-09 | 13D | Compass Therapeutics, Inc. CMPX |
ORBIMED ADVISORS LLC | 12,714,404 20.400% |
12,714,404 (New Position) |
Filing History |
| 2021-07-13 9:24 pm Unchanged |
2021-07-11 | 13D | Acutus Medical, Inc. AFIB |
ORBIMED ADVISORS LLC | 5,810,525 20.400% |
0 (Unchanged) |
Filing History |
| 2021-06-21 8:17 pm Purchase |
2021-06-15 | 13D | Edgewise Therapeutics, Inc. EWTX |
ORBIMED ADVISORS LLC | 3,042,764 7.300% |
3,042,764 (New Position) |
Filing History |
| 2021-04-29 5:17 pm Purchase |
2021-04-26 | 13G | NeuroPace, Inc. NPCE |
ORBIMED ADVISORS LLC | 4,012,281 16.800% |
4,012,281 (New Position) |
Filing History |
| 2021-04-22 5:03 pm Purchase |
2021-04-20 | 13D | Synlogic, Inc. SYBX |
ORBIMED ADVISORS LLC | 246,444 7.400% |
111,111 (+82.10%) |
Filing History |
| 2021-04-20 4:37 pm Purchase |
2021-04-13 | 13G | VectivBio Holding AG VECT |
ORBIMED ADVISORS LLC | 4,830,004 13.800% |
4,830,004 (New Position) |
Filing History |
| 2021-04-14 7:31 pm Purchase |
2021-03-30 | 13D | Ikena Oncology, Inc. IKNA |
ORBIMED ADVISORS LLC | 1,936,886 6.560% |
1,936,886 (New Position) |
Filing History |
| 2021-04-09 4:36 pm Purchase |
2021-04-06 | 13D | Xtant Medical Holdings, Inc. XTNT |
ORBIMED ADVISORS LLC | 72,873,494 84.000% |
70,422 (+0.10%) |
Filing History |
| 2021-04-07 6:00 pm Purchase |
2021-03-30 | 13D | Edgewise Therapeutics, Inc. EWTX |
ORBIMED ADVISORS LLC | 13,679,055 27.800% |
13,679,055 (New Position) |
Filing History |
| 2021-04-07 4:39 pm Sale |
2021-03-01 | 13D | Turning Point Therapeutics, Inc. TPTX |
ORBIMED ADVISORS LLC | 1,743,950 3.600% |
-283,600 (-13.99%) |
Filing History |
| 2021-03-29 4:25 pm Unchanged |
2021-03-25 | 13D | Synlogic, Inc. SYBX |
ORBIMED ADVISORS LLC | 135,333 5.100% |
0 (Unchanged) |
Filing History |
| 2021-03-26 5:07 pm Unchanged |
2021-03-25 | 13D | Graybug Vision, Inc. GRAY |
ORBIMED ADVISORS LLC | 297,382 19.800% |
0 (Unchanged) |
Filing History |
| 2021-03-25 4:15 pm Purchase |
2021-03-23 | 13G | X4 Pharmaceuticals, Inc. XFOR |
ORBIMED ADVISORS LLC | 61,200 7.600% |
19,567 (+47.00%) |
Filing History |
| 2021-03-19 6:06 pm Sale |
2021-03-17 | 13D | ORIC Pharmaceuticals, Inc. ORIC |
ORBIMED ADVISORS LLC | 2,467,292 6.800% |
-298,425 (-10.79%) |
Filing History |
| 2021-03-03 6:50 pm Sale |
2021-03-01 | 13D | SpringWorks Therapeutics, Inc. SWTX |
ORBIMED ADVISORS LLC | 6,186,307 12.600% |
-1,220,000 (-16.47%) |
Filing History |
| 2021-03-01 6:13 pm Purchase |
2021-02-17 | 13D | Decibel Therapeutics, Inc. DBTX |
ORBIMED ADVISORS LLC | 4,061,774 16.700% |
4,061,774 (New Position) |
Filing History |